Tirzepatide, also known as Zepbound, is a groundbreaking FDA-approved dual-action medication designed to help people achieve their weight loss goals more effectively
Eli Lily's Mounjaro is more effective for weight loss than Ozempic, study shows Patients on Mounjaro were more likely to lose 5%, 10% and 15% of their body weight Eli Lily's highly coveted diabetes medicine Mounjaro was shown to be more effective in helping patients who are overweight or obese lose weight when compared with Novo Nordisk's Ozempic, according to a recent study
Please note: For Intramuscular (IM) or Intravenous (IV) use only Store away from direct sunlight 1 ~ 30C Keep out of sight and reach of children Not intended to diagnose, treat, cure or prevent any disease, for promoting wellness only This is a single use ampoule, once opened, use immediately and discard any product not used All products are for sale to trained and insured professionals only who are 18+ years of age
Analysis of cancer incidence observed in clinical trials of liraglutide